101 related articles for article (PubMed ID: 10722866)
21. Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle.
Hayden MA; Nakayama DK
J Surg Res; 1999 Apr; 82(2):222-7. PubMed ID: 10090833
[TBL] [Abstract][Full Text] [Related]
22. Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression.
Trajković V; Badovinac V; Popadić D; Hadzić O; Stojković MM
Immunology; 1997 Nov; 92(3):402-6. PubMed ID: 9486115
[TBL] [Abstract][Full Text] [Related]
23. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes.
Spirlì C; Fabris L; Duner E; Fiorotto R; Ballardini G; Roskams T; Larusso NF; Sonzogni A; Okolicsanyi L; Strazzabosco M
Gastroenterology; 2003 Mar; 124(3):737-53. PubMed ID: 12612912
[TBL] [Abstract][Full Text] [Related]
24. Cardiac fibroblasts express the cAMP-adenosine pathway.
Dubey RK; Gillespie DG; Mi Z; Jackson EK
Hypertension; 2000 Sep; 36(3):337-42. PubMed ID: 10988261
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
Belhassen L; Kelly RA; Smith TW; Balligand JL
J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
[TBL] [Abstract][Full Text] [Related]
26. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
[TBL] [Abstract][Full Text] [Related]
27. Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha.
Mauël J; Ransijn A; Corradin SB; Buchmüller-Rouiller Y
J Leukoc Biol; 1995 Aug; 58(2):217-24. PubMed ID: 7543922
[TBL] [Abstract][Full Text] [Related]
28. Effects of vesnarinone on nitric oxide synthesis in rat cardiac myocytes.
Kurosaki K; Ikeda U; Maeda Y; Shimpo M; Ueno S; Shimada K
Cardiovasc Res; 1998 Apr; 38(1):192-7. PubMed ID: 9683921
[TBL] [Abstract][Full Text] [Related]
29. Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells.
Lee JK; Won JS; Singh AK; Singh I
Neuropharmacology; 2005 Jan; 48(1):151-60. PubMed ID: 15617735
[TBL] [Abstract][Full Text] [Related]
30. Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes.
Collins JL; Vodovotz Y; Yoneyama T; Hatakeyama K; Green AM; Billiar TR
Surgery; 2001 Aug; 130(2):256-64. PubMed ID: 11490358
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
[TBL] [Abstract][Full Text] [Related]
32. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
[TBL] [Abstract][Full Text] [Related]
33. Cyclic AMP-mediated upregulation of the expression of neuronal NO synthase in human A673 neuroepithelioma cells results in a decrease in the level of bioactive NO production: analysis of the signaling mechanisms that are involved.
Boissel JP; Bros M; Schröck A; Gödtel-Armbrust U; Förstermann U
Biochemistry; 2004 Jun; 43(22):7197-206. PubMed ID: 15170357
[TBL] [Abstract][Full Text] [Related]
34. cAMP potentiates beta-amyloid-induced nitric oxide release from microglia.
Pyo H; Jou I; Jung S; Joe E
Neuroreport; 1999 Jan; 10(1):37-40. PubMed ID: 10094129
[TBL] [Abstract][Full Text] [Related]
35. Regulation of inducible nitric oxide synthase by cAMP-elevating phospho-diesterase inhibitors.
Markovic M; Miljkovic Dj; Trajkovic V
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):63-79. PubMed ID: 14561177
[TBL] [Abstract][Full Text] [Related]
36. Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells.
Moon EY; Oh SY; Han GH; Lee CS; Park SK
J Neurosci Res; 2005 Jul; 81(1):38-44. PubMed ID: 15931667
[TBL] [Abstract][Full Text] [Related]
37. PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors.
Timoshenko AV; Lala PK; Chakraborty C
Int J Cancer; 2004 Jan; 108(3):384-9. PubMed ID: 14648704
[TBL] [Abstract][Full Text] [Related]
38. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
39. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
40. Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine TH2-type T cell clone D10.G4.1.
Schmidt J; Hatzelmann A; Fleissner S; Heimann-Weitschat I; Lindstaedt R; Szelenyi I
Immunopharmacology; 1995 Sep; 30(3):191-8. PubMed ID: 8557518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
